WEC
51
6
AAPL
46
-2
MDLZ
38
2
OKE
52
3
LH
38
2
TXN
42
2
VNO
59
3
AEP
51
6
CA
14
10
SJM
28
-8
SIG
54
2
JNPR
63
3
PCG
85
2
NWL
54
5
CNP
65
3
JWN
67
2
HES
56
3
LUV
43
4
ADM
30
2
BA
56
3
WEC
51
6
AAPL
46
-2
MDLZ
38
2
OKE
52
3
LH
38
2
TXN
42
2
VNO
59
3
AEP
51
6
CA
14
10
SJM
28
-8
SIG
54
2
JNPR
63
3
PCG
85
2
NWL
54
5
CNP
65
3
JWN
67
2
HES
56
3
LUV
43
4
ADM
30
2
BA
56
3
Financhill
Back

Aligos Therapeutics Vs. Kymera Therapeutics Industry Stock Comparison

Sell
34

ALGS
Aligos Therapeutics

Last Price:
7.31
Seasonality Move:
-18.08%
Buy
71

KYMR
Kymera Therapeutics

Last Price:
46.27
Seasonality Move:
65.72%
Sell
34
Aligos Therapeutics (ALGS) is a Sell

Is Aligos Therapeutics a Buy, Sell or Hold?

  • The current Aligos Therapeutics [ALGS] share price is $7.38. The Score for ALGS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • ALGS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
71
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $49.02. The Score for KYMR is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

  • The Aligos Therapeutics share price today is $7.38
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $49.02
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.

ALGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.25 Sell
Relative Strength Index (14 RSI): 37.43 Sell
Chaikin Money Flow: 18460 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.68 - 11.86) Sell
Bollinger Bands (100): (9.44 - 14.44) Sell

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 59.12 Buy
Chaikin Money Flow: 317205 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.81 - 49.49) Buy
Bollinger Bands (100): (34.86 - 47.92) Buy

ALGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.36 Buy
20-day SMA: 8.02 Sell
50-day SMA: 11.37 Sell
200-day SMA: 16.05 Sell
8-day EMA: 7.5 Sell
20-day EMA: 8.54 Sell
50-day EMA: 10.46 Sell
200-day EMA: 15.4 Sell

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.58 Buy
20-day SMA: 46.67 Buy
50-day SMA: 46.11 Buy
200-day SMA: 38.62 Buy
8-day EMA: 45.67 Buy
20-day EMA: 45.85 Buy
50-day EMA: 45.2 Buy
200-day EMA: 38.5 Buy

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $37.90 per share, and a decrease next year of $10.24 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.

Aligos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):